Canada markets close in 4 hours 2 minutes

Immunovia AB (publ) (0G8X.L)

LSE - LSE Delayed Price. Currency in SEK
Add to watchlist
1.4000-0.0680 (-4.63%)
At close: 11:13AM BST
Currency in SEK

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 2.60
52-Week Change 3-81.17%
S&P500 52-Week Change 328.04%
52 Week High 37.8250
52 Week Low 30.0000
50-Day Moving Average 31.7083
200-Day Moving Average 32.5836

Share Statistics

Avg Vol (3 month) 321.02k
Avg Vol (10 day) 319.32k
Shares Outstanding 519.53M
Implied Shares Outstanding 6N/A
Float 838.22M
% Held by Insiders 123.49%
% Held by Institutions 12.29%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-15,772.43%

Management Effectiveness

Return on Assets (ttm)-104.98%
Return on Equity (ttm)-219.13%

Income Statement

Revenue (ttm)1.21M
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)-70.00%
Gross Profit (ttm)N/A
EBITDA -148.56M
Net Income Avi to Common (ttm)-260.73M
Diluted EPS (ttm)-7.8050
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)51.18M
Total Cash Per Share (mrq)1.13
Total Debt (mrq)8.79M
Total Debt/Equity (mrq)20.12%
Current Ratio (mrq)2.03
Book Value Per Share (mrq)0.96

Cash Flow Statement

Operating Cash Flow (ttm)-131.59M
Levered Free Cash Flow (ttm)-34.06M